150 related articles for article (PubMed ID: 15073256)
1. The radiotoxicity of 131I therapy of thyroid cancer: assessment by micronucleus assay of B lymphocytes.
Watanabe N; Kanegane H; Kinuya S; Shuke N; Yokoyama K; Kato H; Tomizawa G; Shimizu M; Funada H; Seto H
J Nucl Med; 2004 Apr; 45(4):608-11. PubMed ID: 15073256
[TBL] [Abstract][Full Text] [Related]
2. Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay.
Watanabe N; Yokoyama K; Kinuya S; Shuke N; Shimizu M; Futatsuya R; Michigishi T; Tonami N; Seto H; Goodwin DA
J Nucl Med; 1998 Mar; 39(3):436-40. PubMed ID: 9529288
[TBL] [Abstract][Full Text] [Related]
3. Effect of in vivo exposure to iodine-131 on the frequency and persistence of micronuclei in human lymphocytes.
Livingston GK; Foster AE; Elson HR
J Toxicol Environ Health; 1993; 40(2-3):367-75. PubMed ID: 8230307
[TBL] [Abstract][Full Text] [Related]
4. Radiotoxicity after strontium-89 therapy for bone metastases using the micronucleus assay.
Watanabe N; Yokoyama K; Kinuya S; Shuke N; Shimizu M; Michigishi T; Tonami N; Seto H; Goodwin DA
J Nucl Med; 1998 Dec; 39(12):2077-9. PubMed ID: 9867144
[TBL] [Abstract][Full Text] [Related]
5. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer. A study using the micronucleus test.
Gutiérrez S; Carbonell E; Galofré P; Creus A; Marcos R
Eur J Nucl Med; 1999 Dec; 26(12):1589-96. PubMed ID: 10638411
[TBL] [Abstract][Full Text] [Related]
7. Adaptive response in patients treated with 131I.
Monsieurs MA; Thierens HM; Vral AM; Van De Wiele C; De Ridder LI; Dierckx RA
J Nucl Med; 2000 Jan; 41(1):17-22. PubMed ID: 10647600
[TBL] [Abstract][Full Text] [Related]
8. Chromosome aberrations after treatment with radioactive iodine for thyroid cancer.
Baugnet-Mahieu L; Lemaire M; Léonard ED; Léonard A; Gerber GB
Radiat Res; 1994 Dec; 140(3):429-31. PubMed ID: 7972697
[TBL] [Abstract][Full Text] [Related]
9. Micronucleus yield and colorimetric test as indicators of damage in patients' lymphocytes after 131I therapy.
Catena C; Conti D; Trenta G; Righi E; Breuer F; Melacrinis FF; Montesano T; Ventroni G; Ronga G
J Nucl Med; 2000 Sep; 41(9):1522-4. PubMed ID: 10994733
[TBL] [Abstract][Full Text] [Related]
10. The changes in the thyroid gland after irradiation with 131I or partial thyroidectomy for thyrotoxicosis.
Kennedy JS; Thomson JA
J Pathol; 1974 Feb; 112(2):65-81. PubMed ID: 4834051
[No Abstract] [Full Text] [Related]
11. 131I dosimetry and thyroid stunning.
Gerard SK; Park HM
J Nucl Med; 2003 Dec; 44(12):2039-40; author reply 2040. PubMed ID: 14660731
[No Abstract] [Full Text] [Related]
12. Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma.
M'Kacher R; Légal JD; Schlumberger M; Aubert B; Beron-Gaillard N; Gaussen A; Parmentier C
J Nucl Med; 1997 Mar; 38(3):377-80. PubMed ID: 9074522
[TBL] [Abstract][Full Text] [Related]
13. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H
J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
[TBL] [Abstract][Full Text] [Related]
14. Pilot study for comparison of reticulocyte-micronulei with lymphocyte-micronuclei in human biomonitoring.
Stopper H; Hempel K; Reiners C; Vershenya S; Lorenz R; Vukicevic V; Heidland A; Grawe J
Toxicol Lett; 2005 Apr; 156(3):351-60. PubMed ID: 15763634
[TBL] [Abstract][Full Text] [Related]
15. Chromosome damage in thyroid cells of adults irradiated with x-rays in infancy.
Doida Y; Hoke C; Hempelmann LH
Radiat Res; 1971 Mar; 45(3):645-56. PubMed ID: 5574234
[No Abstract] [Full Text] [Related]
16. Micronuclei and 3AB-index in patients receiving iodine-131 therapy.
Catena C; Villani P; Nastasi R; Conti D; Righi E; Salerno G; Righi VA; Ronga G
J Nucl Biol Med (1991); 1994 Dec; 38(4):586-93. PubMed ID: 7786922
[TBL] [Abstract][Full Text] [Related]
17. Biologic dosimetry in thyroid cancer patients after repeated treatments with iodine-131.
M'Kacher R; Schlumberger M; Légal JD; Violot D; Béron-Gaillard N; Gaussen A; Parmentier C
J Nucl Med; 1998 May; 39(5):825-9. PubMed ID: 9591584
[TBL] [Abstract][Full Text] [Related]
18. Whole-body scanning with radionuclides of iodine, and the controversy of "thyroid stunning".
Kalinyak JE; McDougall IR
Nucl Med Commun; 2004 Sep; 25(9):883-9. PubMed ID: 15319592
[No Abstract] [Full Text] [Related]
19. Thyroid blocking policy--revisited.
Solanki KK; Bomanji JB; Waddington WA; Ell PJ;
Nucl Med Commun; 2004 Nov; 25(11):1071-6. PubMed ID: 15577583
[No Abstract] [Full Text] [Related]
20. [Possible sequelae of the action of radioactive iodine in man].
Il'in LA; Arkhangel'skaia GV
Med Radiol (Mosk); 1973 Aug; 18(8):66-80. PubMed ID: 4801844
[No Abstract] [Full Text] [Related]
[Next] [New Search]
